KARBE FRANK

Average Profitability
92.47%
Insider Buys Quantity
4
Insider Buys Sum
$205,623.95
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of KARBE FRANK

According to the SEC Form 4 filings, KARBE FRANK, being in a position of

  1. director at Phathom Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 12500 shares for $99,084, and sold 0 shares,
    over all time since 2024-12-13, has bought 12500 shares for $99,084, and sold 0 shares.

The largest purchase of all time was on 2024-12-13 and amounted to 12500 shares of Phathom Pharmaceuticals, Inc. for $99,084.

Biography of KARBE FRANK

No biography is available at this moment.

2024-12-13PurchasePhathom Pharmaceuticals, Inc.
PHAT
director
12,500
0.0182%
$7.93$99,084-0.19%
2010-08-24PurchaseExelixis, Inc.
EXEL
EVP & CFO
16,500
0.0147%
$2.98$49,165+182.41%
2008-10-31PurchaseExelixis, Inc.
EXEL
EVP, CFO
7,500
0.007%
$3.37$25,250+43.31%
2008-10-30PurchaseExelixis, Inc.
EXEL
EVP, CFO
10,000
0.0094%
$3.21$32,125+51.69%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.